📰 Topline Data Expected News
Topline Data Expected News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Topline Data Expected. Real-time updates on events, politics, business and more.
March 25, 2024
Topline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of AV-101 for pulmonary arterial hypertension Completed enrollment in the Phase 2b...
March 25, 2024
Topline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of AV-101 for pulmonary arterial...
February 15, 2024
Palatins Focus is Solely on the Development of its Melanocortin Receptor (MCR) System Pipeline PL9643 MELODY-1 Pivotal Phase 3 Study in Dry Eye Disease (DED)...
January 5, 2024
—ARIKAYCE® (amikacin liposome inhalation suspension) Delivers Full-Year 2023 Revenues Exceeding the Upper End of Guidance Range with Unaudited Global Net...
December 11, 2023
Successful Completion Triggers First Milestone Payment Under U.S. Agreement with Nippon Shinyaku-- --HOPE-3 (Cohort A) Enrollment Complete; Topline Data…
March 29, 2023
Topline Data Expected in 2Q 2023SEATTLE, Wash. and VANCOUVER, British Columbia, March 29, 2023 -- Achieve Life Sciences, Inc. , a late-stage pharmaceutical company committed to the global... | March 29, 2023
November 8, 2022
-- Planning to Initiate Phase 2/3 Trial of KPI-012 for Persistent Corneal Epithelial Defect (PCED) in 4Q 2022; Topline Data Expected in 1Q 2024 ---- Ended...
May 3, 2022
Topline Data Expected in 2023ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, May 3, 2022 /PRNewswire/ -- Saol Therapeutics, a privately held, clini...